Cancer Treatment and Research Communications Oncology
Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer
The publisher did not provide an abstract — full text is available via the link below.
Cancer Treatment and Research Communications Oncology
The publisher did not provide an abstract — full text is available via the link below.